These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 20696094

  • 21. Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome.
    Kasim-Karakas SE, Almario RU, Gregory L, Wong R, Todd H, Lasley BL.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):615-20. PubMed ID: 14764771
    [Abstract] [Full Text] [Related]

  • 22. The role of low-grade inflammation in the polycystic ovary syndrome.
    Repaci A, Gambineri A, Pasquali R.
    Mol Cell Endocrinol; 2011 Mar 15; 335(1):30-41. PubMed ID: 20708064
    [Abstract] [Full Text] [Related]

  • 23. Metabolic syndrome in polycystic ovary syndrome.
    Carmina E.
    Minerva Ginecol; 2006 Apr 15; 58(2):109-14. PubMed ID: 16582867
    [Abstract] [Full Text] [Related]

  • 24. Adiposity and metabolic dysfunction in polycystic ovary syndrome.
    Sam S.
    Horm Mol Biol Clin Investig; 2015 Feb 15; 21(2):107-16. PubMed ID: 25781555
    [Abstract] [Full Text] [Related]

  • 25. Nutritional management in women with polycystic ovary syndrome: A review study.
    Faghfoori Z, Fazelian S, Shadnoush M, Goodarzi R.
    Diabetes Metab Syndr; 2017 Nov 15; 11 Suppl 1():S429-S432. PubMed ID: 28416368
    [Abstract] [Full Text] [Related]

  • 26. Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome.
    Moran LJ, Noakes M, Clifton PM, Wittert GA, Williams G, Norman RJ.
    Am J Clin Nutr; 2006 Jul 15; 84(1):77-87. PubMed ID: 16825684
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L, Teede H.
    Hum Reprod Update; 2009 Jul 15; 15(4):477-88. PubMed ID: 19279045
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Role of changes in dietary habits in polycystic ovary syndrome.
    Pasquali R, Gambineri A.
    Reprod Biomed Online; 2004 Apr 15; 8(4):431-9. PubMed ID: 15149567
    [Abstract] [Full Text] [Related]

  • 31. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F, Vuolo L, Palomba S, Lombardi G, Colao A.
    Minerva Ginecol; 2008 Feb 15; 60(1):39-51. PubMed ID: 18277351
    [Abstract] [Full Text] [Related]

  • 32. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN, Merchant R.
    Semin Reprod Med; 2008 Jan 15; 26(1):22-34. PubMed ID: 18181079
    [Abstract] [Full Text] [Related]

  • 33. Obesity and lifestyle management in polycystic ovary syndrome.
    Hoeger KM.
    Clin Obstet Gynecol; 2007 Mar 15; 50(1):277-94. PubMed ID: 17304042
    [Abstract] [Full Text] [Related]

  • 34. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, Votsi E, Diamanti-Kandarakis E.
    Fertil Steril; 2006 Jun 15; 85(6):1778-83. PubMed ID: 16650418
    [Abstract] [Full Text] [Related]

  • 35. Surgical management of metabolic dysfunction in PCOS.
    Escobar-Morreale HF.
    Steroids; 2012 Mar 10; 77(4):312-6. PubMed ID: 22172592
    [Abstract] [Full Text] [Related]

  • 36. Polycystic ovary syndrome (PCOS) and other androgen excess-related conditions: can changes in dietary intake make a difference?
    Liepa GU, Sengupta A, Karsies D.
    Nutr Clin Pract; 2008 Feb 10; 23(1):63-71. PubMed ID: 18203965
    [Abstract] [Full Text] [Related]

  • 37. Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome.
    Ornstein RM, Copperman NM, Jacobson MS.
    J Pediatr Adolesc Gynecol; 2011 Jun 10; 24(3):161-5. PubMed ID: 21419674
    [Abstract] [Full Text] [Related]

  • 38. The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?
    Lansdown A, Rees DA.
    Clin Endocrinol (Oxf); 2012 Dec 10; 77(6):791-801. PubMed ID: 22882204
    [Abstract] [Full Text] [Related]

  • 39. Effect of high-protein or normal-protein diet on weight loss, body composition, hormone, and metabolic profile in southern Brazilian women with polycystic ovary syndrome: a randomized study.
    Toscani MK, Mario FM, Radavelli-Bagatini S, Wiltgen D, Matos MC, Spritzer PM.
    Gynecol Endocrinol; 2011 Nov 10; 27(11):925-30. PubMed ID: 21627406
    [Abstract] [Full Text] [Related]

  • 40. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.
    Mohammadi E, Rafraf M, Farzadi L, Asghari-Jafarabadi M, Sabour S.
    Asia Pac J Clin Nutr; 2012 Nov 10; 21(4):511-8. PubMed ID: 23017309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.